Effectiveness of Food-Based Recommendations for Minangkabau Women of Reproductive Age With Dyslipidemia

September 9, 2019 updated by: Gusnedi, Politeknik Kesehatan Kemenkes Padang

Effectiveness of Optimized Food-Based Recommendations to Improve Dietary Practice, Intake of Problem Nutrient, Nutritional Status and Lipid Profile Among Minangkabau Women of Reproductive Age With Dyslipidemia

This study aimed to assess effectiveness of promoting the optimized Food-based recommendations (FBRs) for improving dietary practices, nutrient intakes, nutritional status and lipid profile among Minangkabau women of reproductive age with dyslipidemia in a community setting. A cluster randomized community-based trial was conducted in Padang City, West Sumatra, Indonesia. Subjects are Minagabau women of reproductive age (20-44 y) with dyslipidemia. The subjects were assigned either into FBR group (n=48) that involved in 12-weeks prolonged contact of FBRs promotion or into non-FBR group, that received once nutrition counselling from usual standard of nutrition program. Baseline and end-line lipid profiles, nutritional status, dietary practice and nutrient intake data were assessed through biochemical assessment, anthropometri, and interview structured questionaire.

Study Overview

Detailed Description

This study was conducted in two sequential phases. The first stage was a formative phase in the form of observational survey to develop and validate food-based recommendations (FBRs). The second phase was an intervention study to assess the effectiveness of the FBRs in improving dietary practice, the intake of problem nutrient, nutritional status and lipid profile of the subject.

Sample size for intervention per group (n=60/group; 2 groups) was expected to detect mean(±SD) differences in LDL-cholesterol concentration (as an secondary outcome) of 14±20 mg/dL as observed in a previous study in other area, with assumption of 80% power and 25% loss of follow up. Potential subjects were identified prior to dyslipidemia screening before intervention. Field nutritionist and volunteer cadres were requested to identify and list women of reproductive age fulfilling the inclusion criteria living in selected sites. An invitation letter was sent to all identified eligible subjects to visit appointed field laboratory to perform blood measurement. Inform consent was signed by all potential participants before blood measurement.

This study did not compare an intervention group (FBR group) with a true control group, but with a comparison group that received once nutrition counselling from usual nutrition health program (non-FBR group). Drawing on concepts of Plan Behavior Theory, persuasive FBR promotion was designed to influence subjects' attitude, subjective norms, perceive behavior control related to dyslipidemia and dietary management, and intention to change. Participants were prompted to set goals for themselves to improve their dietary practices in order to fulfill their nutrient requirements, improve nutritional status and lipid profile.

Study Type

Interventional

Enrollment (Actual)

123

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Sumatra
      • Padang, West Sumatra, Indonesia, 25171
        • Dinas Kesehatan Kota Padang

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 44 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women of reproductive age (20-44 years);
  • native Minangkabau ethnic (both father and mother from the Minangkabau tribe);
  • had abnormal one of isolated blood lipid profiles (cholesterol > 200 mg / dl, LDL-cholesterol >100 mg / dl, HDL < 60 mg/dl, TG > 150 mg/dl);
  • signing a written inform consent.

Exclusion Criteria:

  • in pregnancy;
  • having a history or active smoker and alcoholic addict;
  • has a history of heart disease, diabetes, asthma, cancer, chronic digestive tract disorders, hemophilia and other chronic diseases;
  • routinely taking cholesterol-lowering or blood pressure medications;
  • vegetarians;
  • use estrogen therapy;
  • are participating in other studies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: FBR group
weekly home visit and monthly group meeting for 12 weeks
Prolonged contact through weekly home visits and monthly group meeting for 12 weeks
Other Names:
  • Nutrition education
ACTIVE_COMPARATOR: non-FBR group
once nutrition counseling from standard health care services
once nutrition counselling from health services
Other Names:
  • Standard nutrition care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Dietary practice
Time Frame: baseline (before the intervention) and end-line (after 12-weeks intervention)
Change in food consumption from baseline at 12-week intervention, evaluated based on participant's compliance to the Optimized Food-Based Recommendations. The compliance were measured using one-week Food Frequency Questionnaire (FFQ), stated in servings/week for staple foods. snacks, animal protein (sea fish, eggs, poultry), soy protein (tofu/tempeh), potato, fruits,dark green vegetables (DGLV), total vegetables and fried foods. The recommendations (servings/week) for those food groups/items was 14-21, 7-14, minimum 5, 3-4, 2-3,minimum 7,minimum 5, minimum 7, minimum 5, minimum 14, and maximum 14 respectively. Those who complied with the recommendations was scored 1 for each recommendations, and 0 for those who did not. The total score for the compliance to the FBRs was 0-11. Higher score represents better participant's compliance
baseline (before the intervention) and end-line (after 12-weeks intervention)
Change in energy intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for energy intake( in Kcal). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software
baseline (before intervention and end-line (after 12-weeks interventions)
Change in protein intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for protein intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software
baseline (before intervention and end-line (after 12-weeks interventions)
Change in total fat intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for total fat intake( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in carbohydrate intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for carbohydrate intake ( in gram)
baseline (before intervention and end-line (after 12-weeks interventions)
Change in poly unsaturated fatty acids (PUFA) intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for PUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in mono unsaturated fatty acids (MUFA) intakes
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for MUFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in saturated fatty acids (SFA) intakes
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for SFA intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in PUFA/SFA (P/S) ratio
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for P/S
baseline (before intervention and end-line (after 12-weeks interventions)
Change in dietary fiber intakes
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for dietary fiber intake ( in gram). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in iron (Fe) intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for iron intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)
Change in zinc (Zn) intake
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change from baseline at 12-week intervention for zinc intake ( in mg). The intake was measured through interview using two replicates 24-hour food recall on non-consecutive days. The foods were converted to energy and nutrients based on Indonesia food composition tables available in nutrisurvey software.
baseline (before intervention and end-line (after 12-weeks interventions)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body weight
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change in Body weight (in Kg) from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)
Change in waist circumference
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
change of waist circumference (in cm), from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)
Change in total cholesterol level
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of total cholesterol (in mg/dL) from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)
Change in Low Desnsity Lipoprotein (LDL) cholesterol
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of LDL (in mg/dL) from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)
Change in serum High Density Lipoprotein (HDL) cholesterol
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of HDL (mg/dL) from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)
Change in serum triglyceride (TG)
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of TG (mg/dL) from baseline at 12-week intervention
baseline (before intervention and end-line (after 12-weeks interventions)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Mass Index
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change in body mass index (kg/m2) from baseline at 12-week intervention, calculated from body weight (in kg) divided by square body height (in meter suquare), endline minus baseline
baseline (before intervention and end-line (after 12-weeks interventions)
Change in Castelli's Index
Time Frame: baseline (before intervention and end-line (after 12-weeks interventions)
Change of Castelli's index from baseline at 12-week intervention, calculated from the total cholesterol level divided by serum HDL
baseline (before intervention and end-line (after 12-weeks interventions)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Murdani Abdullah, Indonesia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 7, 2019

Primary Completion (ACTUAL)

May 5, 2019

Study Completion (ACTUAL)

June 10, 2019

Study Registration Dates

First Submitted

September 4, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (ACTUAL)

September 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 11, 2019

Last Update Submitted That Met QC Criteria

September 9, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Promotion of Food-based recommendations

3
Subscribe